Assignee
EMPIRICO INC
US10 patents
Top patents by PatentIndex Score
US11116778B2Sep 14, 2021
Prodrugs of ALOX-15 inhibitors and methods of using the same
EMPIRICO INC9 citations83
US11879125B2Jan 23, 2024
GalNAc compositions for improving siRNA bioavailability
EMPIRICO INC3 citations72
US11377658B2Jul 5, 2022
Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases
EMPIRICO INC2 citations70
US10941404B2Mar 9, 2021
Treatment of angiopoietin like 7 (ANGPTL7) related diseases
EMPIRICO INC2 citations69
US12258564B2Mar 25, 2025
GalNAc compositions for improving siRNA bioavailability
EMPIRICO INC0 citations60
US12258563B2Mar 25, 2025
Modified oligonucleotides
EMPIRICO INC0 citations60
US11666588B2Jun 6, 2023
Prodrugs of ALOX-15 inhibitors and methods of using the same
EMPIRICO INC0 citations59
US11452738B2Sep 27, 2022
Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts
EMPIRICO INC0 citations59
US12378556B2Aug 5, 2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases
EMPIRICO INC0 citations58
US12312586B2May 27, 2025
Treatment of MST1 related diseases and disorders
EMPIRICO INC0 citations53